<!DOCTYPE html> <html> <head> <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width, initial-scale=1" /> <meta name="description" content="The about page is provides a brief introduction." /> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@iandennismiller" /> <meta name="twitter:title" content="About" /> <meta name="twitter:description" content="The about page is provides a brief introduction." /> <meta name="twitter:image" content="http://covindex.com/media/thumb-big.jpg" /> <meta property="og:site_name" content="CoVIndex"/> <meta property="og:type" content="website"/> <meta property="og:title" content="CoVIndex - Article"/> <meta property="og:description" content="The about page is provides a brief introduction."/> <meta property="og:url" content="http://covindex.com/about/"/> <meta property="og:image" content="http://covindex.com/media/thumb-big.jpg"/> <link rel="sitemap" href="/sitemap.xml" /> <link rel="canonical" href="http://covindex.com/about/" /> <link rel="alternate" type="application/rss+xml" title="CoVIndex" href="http://covindex.com/blog/feed.xml" /> <title>CoVIndex - Article</title> <style> body,h1,h2,h3,h4,h5,h6,p,blockquote,pre,hr,dl,dd,ol,ul,figure{margin:0;padding:0}body{font:400 16px/1.5 "Helvetica Neue",Helvetica,Arial,sans-serif;color:#111;background-color:#fdfdfd;-webkit-text-size-adjust:100%;-webkit-font-feature-settings:"kern" 1;-moz-font-feature-settings:"kern" 1;-o-font-feature-settings:"kern" 1;font-feature-settings:"kern" 1;font-kerning:normal}h1,h2,h3,h4,h5,h6,p,blockquote,pre,ul,ol,dl,figure,.highlight{margin-bottom:15px}img{max-width:100%;vertical-align:middle}figure>img{display:block}figcaption{font-size:14px}ul,ol{margin-left:30px}li>ul,li>ol{margin-bottom:0}h1,h2,h3,h4,h5,h6{font-weight:400}a{color:#2a7ae2;text-decoration:none}a:visited{color:#1756a9}a:hover{color:#111;text-decoration:underline}blockquote{color:#828282;border-left:4px solid #e8e8e8;padding-left:15px;font-size:18px;letter-spacing:-1px;font-style:italic}blockquote>:last-child{margin-bottom:0}pre,code{font-size:15px;border:1px solid #e8e8e8;border-radius:3px;background-color:#eef}code{padding:1px 5px}pre{padding:8px 12px;overflow-x:auto}pre>code{border:0;padding-right:0;padding-left:0}.wrapper{max-width:-webkit-calc(800px - (30px * 2));max-width:calc(800px - (30px * 2));margin-right:auto;margin-left:auto;padding-right:30px;padding-left:30px}@media screen and (max-width: 800px){.wrapper{max-width:-webkit-calc(800px - (30px));max-width:calc(800px - (30px));padding-right:15px;padding-left:15px}}.wrapper:after,.footer-col-wrapper:after{content:"";display:table;clear:both}.icon>svg{display:inline-block;width:16px;height:16px;vertical-align:middle}.icon>svg path{fill:#828282}.site-header{border-top:5px solid #424242;border-bottom:1px solid #e8e8e8;min-height:56px;position:relative}.site-title{font-size:26px;font-weight:300;line-height:56px;letter-spacing:-1px;margin-bottom:0;float:left}.site-title,.site-title:visited{color:#424242}.site-nav{float:right;line-height:56px}.site-nav .menu-icon{display:none}.site-nav .page-link{color:#111;line-height:1.5}.site-nav .page-link:not(:last-child){margin-right:20px}@media screen and (max-width: 600px){.site-nav{position:absolute;top:9px;right:15px;background-color:#fdfdfd;border:1px solid #e8e8e8;border-radius:5px;text-align:right}.site-nav .menu-icon{display:block;float:right;width:36px;height:26px;line-height:0;padding-top:10px;text-align:center}.site-nav .menu-icon>svg{width:18px;height:15px}.site-nav .menu-icon>svg path{fill:#424242}.site-nav .trigger{clear:both;display:none}.site-nav:hover .trigger{display:block;padding-bottom:5px}.site-nav .page-link{display:block;padding:5px 10px;margin-left:20px}.site-nav .page-link:not(:last-child){margin-right:0}}.site-footer{border-top:1px solid #e8e8e8;padding:30px 0}.footer-heading{font-size:18px;margin-bottom:15px}.contact-list,.social-media-list{list-style:none;margin-left:0}.footer-col-wrapper{font-size:15px;color:#828282;margin-left:-15px}.footer-col{float:left;margin-bottom:15px;padding-left:15px}.footer-col-1{width:-webkit-calc(35% - (30px / 2));width:calc(35% - (30px / 2))}.footer-col-2{width:-webkit-calc(20% - (30px / 2));width:calc(20% - (30px / 2))}.footer-col-3{width:-webkit-calc(45% - (30px / 2));width:calc(45% - (30px / 2))}@media screen and (max-width: 800px){.footer-col-1,.footer-col-2{width:-webkit-calc(50% - (30px / 2));width:calc(50% - (30px / 2))}.footer-col-3{width:-webkit-calc(100% - (30px / 2));width:calc(100% - (30px / 2))}}@media screen and (max-width: 600px){.footer-col{float:none;width:-webkit-calc(100% - (30px / 2));width:calc(100% - (30px / 2))}}.page-content{padding:30px 0}.page-heading{font-size:20px}.post-list{margin-left:0;list-style:none}.post-list>li{margin-bottom:30px}.post-meta{font-size:14px;color:#828282}.post-link{display:block;font-size:24px}.post-header{margin-bottom:30px}.post-title{font-size:42px;letter-spacing:-1px;line-height:1}@media screen and (max-width: 800px){.post-title{font-size:36px}}.post-content{margin-bottom:30px}.post-content h2{font-size:32px}@media screen and (max-width: 800px){.post-content h2{font-size:28px}}.post-content h3{font-size:26px}@media screen and (max-width: 800px){.post-content h3{font-size:22px}}.post-content h4{font-size:20px}@media screen and (max-width: 800px){.post-content h4{font-size:18px}}.highlight{background:#fff}.highlighter-rouge .highlight{background:#eef}.highlight .c{color:#998;font-style:italic}.highlight .err{color:#a61717;background-color:#e3d2d2}.highlight .k{font-weight:bold}.highlight .o{font-weight:bold}.highlight .cm{color:#998;font-style:italic}.highlight .cp{color:#999;font-weight:bold}.highlight .c1{color:#998;font-style:italic}.highlight .cs{color:#999;font-weight:bold;font-style:italic}.highlight .gd{color:#000;background-color:#fdd}.highlight .gd .x{color:#000;background-color:#faa}.highlight .ge{font-style:italic}.highlight .gr{color:#a00}.highlight .gh{color:#999}.highlight .gi{color:#000;background-color:#dfd}.highlight .gi .x{color:#000;background-color:#afa}.highlight .go{color:#888}.highlight .gp{color:#555}.highlight .gs{font-weight:bold}.highlight .gu{color:#aaa}.highlight .gt{color:#a00}.highlight .kc{font-weight:bold}.highlight .kd{font-weight:bold}.highlight .kp{font-weight:bold}.highlight .kr{font-weight:bold}.highlight .kt{color:#458;font-weight:bold}.highlight .m{color:#099}.highlight .s{color:#d14}.highlight .na{color:teal}.highlight .nb{color:#0086B3}.highlight .nc{color:#458;font-weight:bold}.highlight .no{color:teal}.highlight .ni{color:purple}.highlight .ne{color:#900;font-weight:bold}.highlight .nf{color:#900;font-weight:bold}.highlight .nn{color:#555}.highlight .nt{color:navy}.highlight .nv{color:teal}.highlight .ow{font-weight:bold}.highlight .w{color:#bbb}.highlight .mf{color:#099}.highlight .mh{color:#099}.highlight .mi{color:#099}.highlight .mo{color:#099}.highlight .sb{color:#d14}.highlight .sc{color:#d14}.highlight .sd{color:#d14}.highlight .s2{color:#d14}.highlight .se{color:#d14}.highlight .sh{color:#d14}.highlight .si{color:#d14}.highlight .sx{color:#d14}.highlight .sr{color:#009926}.highlight .s1{color:#d14}.highlight .ss{color:#990073}.highlight .bp{color:#999}.highlight .vc{color:teal}.highlight .vg{color:teal}.highlight .vi{color:teal}.highlight .il{color:#099}.zoomify{cursor:pointer;cursor:-webkit-zoom-in;cursor:zoom-in}.zoomify.zoomed{cursor:-webkit-zoom-out;cursor:zoom-out;padding:0;margin:0;border:none;border-radius:0;box-shadow:none;position:relative;z-index:1501}.zoomify-shadow{position:fixed;top:0;left:0;right:0;bottom:0;width:100%;height:100%;display:block;z-index:1500;background:rgba(0,0,0,0.3);opacity:0}.zoomify-shadow.zoomed{opacity:1;cursor:pointer;cursor:-webkit-zoom-out;cursor:zoom-out}.share-button{border:1px solid gray;padding:3px;font-size:10pt;background:#f0f0f0;color:#000;-moz-border-radius:4px;border-radius:4px;margin-right:1em}.share-button:visited{color:#000}.share-button:hover{text-decoration:none;background:#dcdcdc}.share-button .icon{vertical-align:text-bottom}.social{margin-bottom:1em}.footer-col-2{text-align:right}.aside{float:right;width:15em;font-style:italic;border:1px dotted;background:1px dotted;padding:1em;margin-left:1em;margin-top:1em;margin-bottom:1em}#content-license{font-size:8pt;text-align:center}@media screen and (max-width: 600px){#account_name_query{width:5em}#example_list li{display:list-item !important}#board{width:18em}.footer-col-2{text-align:left}.aside{float:none;margin:0px auto;width:90%;margin-bottom:2em}} </style> <script src="/js/main.js"></script> </head> <body> <header class="site-header"> <div class="wrapper"> <a class="site-title" href="/"><img width="24" height="24" src="data:image/png;base64,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" /> CoVIndex</a> <nav class="site-nav"> <a href="#" class="menu-icon"> <svg viewBox="0 0 18 15"> <path fill="#424242" d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.031C17.335,0,18,0.665,18,1.484L18,1.484z"/> <path fill="#424242" d="M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0c0-0.82,0.665-1.484,1.484-1.484 h15.031C17.335,6.031,18,6.696,18,7.516L18,7.516z"/> <path fill="#424242" d="M18,13.516C18,14.335,17.335,15,16.516,15H1.484C0.665,15,0,14.335,0,13.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.031C17.335,12.031,18,12.696,18,13.516L18,13.516z"/> </svg> </a> <div class="trigger"> <a class="page-link" href="/about/">About</a> <a class="page-link" href="/blog/">Blog</a> </div> </nav> </div> </header> <div class="page-content"> <div class="wrapper"> 
    
    <article class="post">

        <header class="post-header">
          <h1 class="post-title">holmes-kathryn-v</h1>
        </header>
      
        <div class="post-content">
          <div class="home">

    <div style="margin-bottom: 1em;">
        Holmes, Kathryn V.
    </div>

    <h2>Articles</h2>

    <ul>
    
        <li><a href="/articles/bonavia2003identificationhcove.html">[view]</a> Bonavia, Aurelio and Zelus, Bruce D. and Wentworth, David E. and Talbot, Pierre J. and Holmes, Kathryn V.. (2003). Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E</li>
    
        <li><a href="/articles/breslin2003humanc.html">[view]</a> Breslin, Jamie J. and Mørk, Irene and Smith, M. K. and Vogel, Lotte K. and Hemmila, Erin M. and Bonavia, Aurelio and Talbot, Pierre J. and Sjöströ, Hans and Norén, Ove and Holmes, Kathryn V.. (2003). Human coronavirus 229E: Receptor binding domain and neutralization by soluble receptor at 37°C</li>
    
        <li><a href="/articles/coutelier1994bcoronavirus.html">[view]</a> Coutelier, Jean‐Paul ‐P and Godfraind, Catherine and Dveksler, Gabriela S. and Wysocka, Maria and Cardellichio, Christine B. and Noël, Henri and Holmes, Kathryn V.. (1994). B lymphocyte and macrophage expression of carcinoembryonic antigen‐related adhesion molecules that serve as receptors for murine coronavirus</li>
    
        <li><a href="/articles/dominguez2006blindedsyndrome.html">[view]</a> Dominguez, Samuel R. and Anderson, Marsha S. and Glodé, Mary P. and Robinson, Christine C. and Holmes, Kathryn V.. (2006). Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome</li>
    
        <li><a href="/articles/dominguez2007detectionamerica.html">[view]</a> Dominguez, Samuel R. and O'Shea, Thomas J. and Oko, Lauren M. and Holmes, Kathryn V.. (2007). Detection of group 1 coronaviruses in bats in North America</li>
    
        <li><a href="/articles/dominguez2009detectioncolorado.html">[view]</a> Dominguez, Samuel R. and Robinson, Christine C. and Holmes, Kathryn V.. (2009). Detection of four human coronaviruses in respiratory infections in children: A one-year study in Colorado</li>
    
        <li><a href="/articles/dominguez2014isolationbetacoronaviruses.html">[view]</a> Dominguez, Samuel R. and Shrivastava, Susmita and Berglund, Andrew and Qian, Zhaohui and Góes, Luiz Gustavo Bentim and Halpin, Rebecca A. and Fedorova, Nadia and Ransier, Amy and Weston, Philip A. and Durigon, Edison Luiz and Jerez, José Antonio and Robinson, Christine C. and Town, Christopher D. and Holmes, Kathryn V.. (2014). Isolation, propagation, genome analysis and epidemiology of HKU1 betacoronaviruses</li>
    
        <li><a href="/articles/dominguez2012genomicrecombination.html">[view]</a> Dominguez, Samuel R. and Sims, Gregory E. and Wentworth, David E. and Halpin, Rebecca A. and Robinson, Christine C. and Town, Christopher D. and Holmes, Kathryn V.. (2012). Genomic analysis of 16 Colorado human NL63 coronaviruses identifies a new genotype, high sequence diversity in the N-terminal domain of the spike gene and evidence of recombination</li>
    
        <li><a href="/articles/funk2009ratresponse.html">[view]</a> Funk, C. Joel and Manzer, Rizwan and Miura, Tanya A. and Groshong, Steve D. and Ito, Yoko and Travanty, Emily A. and Leete, Jennifer and Holmes, Kathryn V. and Mason, Robert J.. (2009). Rat respiratory coronavirus infection: Replication in airway and alveolar epithelial cells and the innate immune response</li>
    
        <li><a href="/articles/hemmila2004ceacamaa.html">[view]</a> Hemmila, Erin and Turbide, Claire and Olson, Melanie and Jothy, Serge and Holmes, Kathryn V. and Beauchemin, Nicole. (2004). Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59</li>
    
        <li><a href="/articles/holmes1981tunicamycinglycoprotein.html">[view]</a> Holmes, Kathryn V. and Doller, Elizabeth W. and Sturman, Lawrence S.. (1981). Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein</li>
    
        <li><a href="/articles/holmes2013thepneumonia.html">[view]</a> Holmes, Kathryn V. and Dominguez, Samuel R.. (2013). The new age of virus discovery: Genomic analysis of a novel human betacoronavirus isolated from a fatal case of pneumonia</li>
    
        <li><a href="/articles/howard2008aromaticfusion.html">[view]</a> Howard, Megan W. and Travanty, Emily A. and Jeffers, Scott A. and Smith, M. K. and Wennier, Sonia T. and Thackray, Larissa B. and Holmes, Kathryn V.. (2008). Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion</li>
    
        <li><a href="/articles/jeffers2004cdlcoronavirus.html">[view]</a> Jeffers, Scott A. and Tusell, Sonia M. and Gillim-Ross, Laura and Hemmila, Erin M. and Achenbach, Jenna E. and Babcock, Gregory J. and Thomas Jr., William D. and Thackray, Larissa B. and Young, Mark D. and Mason, Robert J. and Ambrosino, Donna M. and Wentworth, David E. and DeMartini, James C. and Holmes, Kathryn V.. (2004). CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus</li>
    
        <li><a href="/articles/jordan1989expressioncoronavirus.html">[view]</a> Jordan, Craig A. and Friedrich, Victor L. and Godfraind, Catherine and Cardellechio, Christine B. and Holmes, Kathryn V. and Dubois‐Dalcq, Monique. (1989). Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus</li>
    
        <li><a href="/articles/miura2009hostpathogencells.html">[view]</a> Miura, Tanya A. and Holmes, Kathryn V.. (2009). Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells</li>
    
        <li><a href="/articles/miura2008themice.html">[view]</a> Miura, Tanya A. and Travanty, Emily A. and Oko, Lauren and Bielefeldt-Ohmann, Helle and Weiss, Susan R. and Beauchemin, Nicole and Holmes, Kathryn V.. (2008). The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- mice</li>
    
        <li><a href="/articles/miura2007ratchemokines.html">[view]</a> Miura, Tanya A. and Wang, Jieru and Holmes, Kathryn V. and Mason, Robert J.. (2007). Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines</li>
    
        <li><a href="/articles/osborne2011alphacoronaviruseshumans.html">[view]</a> Osborne, Christina and Cryan, Paul M. and O'Shea, Thomas J. and Oko, Lauren M. and Ndaluka, Christina and Calisher, Charles H. and Berglund, Andrew D. and Klavetter, Mead L. and Bowen, Richard A. and Holmes, Kathryn V. and Dominguez, Samuel R.. (2011). Alphacoronaviruses in new World bats: Prevalence, persistence, phylogeny, and potential for interaction with humans</li>
    
        <li><a href="/articles/ou2016identificationglycoproteins.html">[view]</a> Ou, Xiuyuan and Zheng, Wangliang and Shan, Yiwei and Mu, Zhixia and Dominguez, Samuel R. and Holmes, Kathryn V. and Qian, Zhaohui. (2016). Identification of the fusion peptide-containing region in betacoronavirus spike glycoproteins</li>
    
        <li><a href="/articles/peng2011crystalreceptor.html">[view]</a> Peng, Guiqing and Sun, Dawei and Rajashankar, Kanagalaghatta R. and Qian, Zhaohui and Holmes, Kathryn V. and Li, Fang. (2011). Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor</li>
    
        <li><a href="/articles/peng2012crystaldomain.html">[view]</a> Peng, Guiqing and Xu, Liqing and Lin, Yi Lun and Chen, Lang and Pasquarella, Joseph R. and Holmes, Kathryn V. and Li, Fang. (2012). Crystal structure of bovine coronavirus spike protein lectin domain</li>
    
        <li><a href="/articles/peng2017structuralreceptor.html">[view]</a> Peng, Guiqing and Yang, Yang and Pasquarella, Joseph R. and Xu, Liqing and Qian, Zhaohui and Holmes, Kathryn V. and Li, Fang. (2017). Structural and molecular evidence suggesting coronavirus-driven evolution of mouse receptor</li>
    
        <li><a href="/articles/qian2015identificationhku.html">[view]</a> Qian, Zhaohui and Ou, Xiuyuan and Góes, Luiz Gustavo Bentim and Osborne, Christina and Castano, Anna and Holmes, Kathryn V. and Dominguez, Samuel R.. (2015). Identification of the receptor-binding domain of the spike glycoprotein of human betacoronavirus HKU1</li>
    
        <li><a href="/articles/qian2013innatesyndromecoronavirus.html">[view]</a> Qian, Zhaohui and Travanty, Emily A. and Oko, Lauren and Edeen, Karen and Berglund, Andrew and Wang, Jieru and Ito, Yoko and Holmes, Kathryn V. and Mason, Robert J.. (2013). Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus</li>
    
        <li><a href="/articles/schickli2004thecells.html">[view]</a> Schickli, Jeanne H. and Thackray, Larissa B. and Sawicki, Stanley G. and Holmes, Kathryn V.. (2004). The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells</li>
    
        <li><a href="/articles/smith1991monoclonalvivo.html">[view]</a> Smith, Abigail L. and Cardellichio, Christine B. and Winograd, Deborah F. and De Souza, Mark S. and Barthold, Stephen W. and Holmes, Kathryn V.. (1991). Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo</li>
    
        <li><a href="/articles/sturman1977characterizationanalysis.html">[view]</a> Sturman, Lawrence S. and Holmes, Kathryn V.. (1977). Characterization of a coronavirus. II. Glycoproteins of the viral envelope: Tryptic peptide analysis</li>
    
        <li><a href="/articles/tan2002crystalfamily.html">[view]</a> Tan, Kemin and Zelus, Bruce D. and Meijers, Rob and Liu, Jin Huan and Bergelson, Jeffrey M. and Duke, Norma and Zhang, Rongguang and Joachimiak, Andrzej and Holmes, Kathryn V. and Wang, Jia Huai. (2002). Crystal structure of murine sCEACAM1a[1, 4]: A coronavirus receptor in the CEA family</li>
    
        <li><a href="/articles/thackray2004aminomhva.html">[view]</a> Thackray, Larissa B. and Holmes, Kathryn V.. (2004). Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59</li>
    
        <li><a href="/articles/thackray2005substitutionsmhva.html">[view]</a> Thackray, Larissa B. and Turner, Brian C. and Holmes, Kathryn V.. (2005). Substitutions of conserved amino acids in the receptor-binding domain of the spike glycoprotein affect utilization of murine CEACAM1a by the murine coronavirus MHV-A59</li>
    
        <li><a href="/articles/tripet2004structuralcore.html">[view]</a> Tripet, Brian and Howard, Megan W. and Jobling, Michael and Holmes, Randall K. and Holmes, Kathryn V. and Hodges, Robert S.. (2004). Structural characterization of the SARS-coronavirus spike S fusion protein core</li>
    
        <li><a href="/articles/tripet2006templatebasedsarscoronavirus.html">[view]</a> Tripet, Brian and Kao, Daniel J. and Jeffers, Scott A. and Holmes, Kathryn V. and Hodges, Robert S.. (2006). Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus</li>
    
        <li><a href="/articles/tsai2003thestrain.html">[view]</a> Tsai, Jean C. and Zelus, Bruce D. and Holmes, Kathryn V. and Weiss, Susan R.. (2003). The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain</li>
    
        <li><a href="/articles/turner2004receptordependentcells.html">[view]</a> Turner, Brian C. and Hemmila, Erin M. and Beauchemin, Nicole and Holmes, Kathryn V.. (2004). Receptor-Dependent Coronavirus Infection of Dendritic Cells</li>
    
        <li><a href="/articles/tusell2007mutationalrange.html">[view]</a> Tusell, Sonia M. and Schittone, Stephanie A. and Holmes, Kathryn V.. (2007). Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range</li>
    
        <li><a href="/articles/wentworth2005cellsvivo.html">[view]</a> Wentworth, David E. and Tresnan, D. B. and Turner, B. C. and Lerman, I. R. and Bullis, B. and Hemmila, E. M. and Levis, R. and Shapiro, L. H. and Holmes, Kathryn V.. (2005). Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo</li>
    
        <li><a href="/articles/yeager1992humane.html">[view]</a> Yeager, Curtis L. and Ashmun, Richard A. and Williams, Richard K. and Cardellichio, Christine B. and Shapiro, Linda H. and Look, A. Thomas and Holmes, Kathryn V.. (1992). Human aminopeptidase N is a receptor for human coronavirus 229E</li>
    
        <li><a href="/articles/zelus2003conformational.html">[view]</a> Zelus, Bruce D. and Schickli, Jeanne H. and Blau, Dianna M. and Weiss, Susan R. and Holmes, Kathryn V.. (2003). Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8</li>
    
    </ul>

</div>

        </div>
     
      </article>

</div> </div> <footer class="site-footer"> <div class="wrapper"> <!-- <h2 class="footer-heading">CoVIndex</h2> --> <div class="footer-col-wrapper"> <div class="footer-col footer-col-1"> <ul class="contact-list"> <!-- <li>CoVIndex</li> --> <li> <a class="outbound" href="http://covindex.com/"><span class="icon icon--www"><svg xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://creativecommons.org/ns#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:svg="http://www.w3.org/2000/svg" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 14.17475 14.17475" height="14.17475" width="14.17475" xml:space="preserve" version="1.1" id="svg4244"><metadata id="metadata4250"><rdf:RDF><cc:Work rdf:about=""><dc:format>image/svg+xml</dc:format><dc:type rdf:resource="http://purl.org/dc/dcmitype/StillImage" /><dc:title></dc:title></cc:Work></rdf:RDF></metadata><defs id="defs4248"><clipPath id="clipPath4258" clipPathUnits="userSpaceOnUse"><path id="path4260" d="m 0,11.34 11.34,0 L 11.34,0 0,0 0,11.34 Z" /></clipPath></defs><g transform="matrix(1.25,0,0,-1.25,0,14.17475)" id="g4252"><g style="stroke:#58928a;stroke-opacity:1" transform="matrix(0.97909434,0.20340668,-0.20340668,0.97909434,1.2718042,-1.0347843)" id="g4254"><g style="stroke:#58928a;stroke-opacity:1" clip-path="url(#clipPath4258)" id="g4256"><g style="stroke:#58928a;stroke-opacity:1" transform="translate(0.563,5.6699)" id="g4262"><path id="path4264" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="m 0,0 c 0,2.82 2.287,5.107 5.107,5.107 2.82,0 5.107,-2.287 5.107,-5.107 0,-2.82 -2.287,-5.107 -5.107,-5.107 C 2.287,-5.107 0,-2.82 0,0 Z" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(8.4111,5.6704)" id="g4266"><path id="path4268" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="m 0,0 c 0,2.819 -1.259,5.106 -2.811,5.106 -1.552,0 -2.811,-2.287 -2.811,-5.106 0,-2.823 1.259,-5.108 2.811,-5.108 C -1.259,-5.108 0,-2.823 0,0 Z" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(5.6699,10.647)" id="g4270"><path id="path4272" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="M 0,0 0,-9.855" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(0.563,5.6699)" id="g4274"><path id="path4276" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="M 0,0 10.214,0" /></g></g></g></g></svg></span> <span class="username">http://covindex.com/</span></a> </li> <li> <a class="outbound" href="https://twitter.com/iandennismiller"><span class="icon icon--twitter"><svg viewBox="0 0 16 16"><path fill="#828282" d="M15.969,3.058c-0.586,0.26-1.217,0.436-1.878,0.515c0.675-0.405,1.194-1.045,1.438-1.809c-0.632,0.375-1.332,0.647-2.076,0.793c-0.596-0.636-1.446-1.033-2.387-1.033c-1.806,0-3.27,1.464-3.27,3.27 c0,0.256,0.029,0.506,0.085,0.745C5.163,5.404,2.753,4.102,1.14,2.124C0.859,2.607,0.698,3.168,0.698,3.767 c0,1.134,0.577,2.135,1.455,2.722C1.616,6.472,1.112,6.325,0.671,6.08c0,0.014,0,0.027,0,0.041c0,1.584,1.127,2.906,2.623,3.206 C3.02,9.402,2.731,9.442,2.433,9.442c-0.211,0-0.416-0.021-0.615-0.059c0.416,1.299,1.624,2.245,3.055,2.271 c-1.119,0.877-2.529,1.4-4.061,1.4c-0.264,0-0.524-0.015-0.78-0.046c1.447,0.928,3.166,1.469,5.013,1.469 c6.015,0,9.304-4.983,9.304-9.304c0-0.142-0.003-0.283-0.009-0.423C14.976,4.29,15.531,3.714,15.969,3.058z"/></svg> </span><span class="username">iandennismiller</span></a> </li> </ul> </div> <div class="footer-col footer-col-2"> <img src="data:image/png;base64,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" width="50" style="margin-top: 6px;" /> </div> <div class="footer-col footer-col-3"> <div>CoVIndex: Coronavirus Research and Researchers</div> </div> </div> </div> <div id="content-license"> <a href="/license/">cc 2020</a> </div> </footer> </body> </html>
